Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jan;68(1):113-9.
doi: 10.1001/archneurol.2010.334.

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment

Ozioma C Okonkwo  1 , Michelle M Mielke, H Randall Griffith, Abhay R Moghekar, Richard J O'Brien, Leslie M Shaw, John Q Trojanowski, Marilyn S Albert; Alzheimer's Disease Neuroimaging Initiative
Affiliations
Comparative Study

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment

Ozioma C Okonkwo et al. Arch Neurol. 2011 Jan.

Abstract

Objectives: To examine the effect of specific cerebrospinal fluid (CSF) profiles on the rate of cognitive decline, disease progression, and risk of conversion to Alzheimer disease (AD) dementia in patients with amnestic mild cognitive impairment (MCI).

Design: Total tau (T-tau), tau phosphorylated at threonine 181, and β-amyloid 1-42 peptide (Aβ42) were immunoassayed in CSF samples obtained from patients with MCI enrolled in the Alzheimer's Disease Neuroimaging Initiative. Patients were then stratified by CSF profiles: (1) normal T-tau and normal Aβ42 (ie, normal-T-tauAβ42), (2) normal T-tau but abnormal Aβ42 (ie, abnormal-Aβ42), (3) abnormal T-tau but normal Aβ42 (ie, abnormal-T-tau), and (4) abnormal T-tau and abnormal Aβ42 (ie, abnormal-T-tauAβ42).

Setting: Fifty-eight sites in the United States and Canada.

Participants: One hundred ninety-five patients with MCI.

Main outcome measures: A composite cognitive measure, the Clinical Dementia Rating Scale-sum of boxes subscale, and conversion to AD dementia.

Results: Patients with MCI with a CSF profile of abnormal-Aβ42 or abnormal-T-tauAβ42 experienced a faster rate of decline on the composite cognitive measure and the Clinical Dementia Rating Scale-sum of boxes subscale compared with those with normal-T-tauAβ42. They also had a greater risk of converting to AD dementia relative to the normal-T-tauAβ42 group. In contrast, those with a CSF profile of abnormal-T-tau did not differ from the normal-T-tauAβ42 group on any outcome. These findings were generally replicated when the sample was reclassified by patterns of tau phosphorylated at threonine 181 and Aβ42 abnormalities.

Conclusions: β-Amyloid abnormalities but not tau alterations are associated with cognitive deterioration, disease progression, and increased risk of conversion to AD dementia in patients with MCI. Patients with abnormal Aβ42 may be prime candidates for drug treatment and clinical trials in MCI.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Trajectories of change on the composite cognitive measure
Figure 2
Figure 2. Trajectories of change on the CDR-SB
Figure 3
Figure 3. Cumulative survival plots of rate of conversion to AD
See this image and copyright information in PMC

References

    1. Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 2009;65:403–13. - PMC - PubMed
    1. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurology. 2003;2:605–13. - PubMed
    1. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study. Lancet Neurology. 2006;5:228–34. - PubMed
    1. Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302:385–93. - PubMed
    1. Nordlund A, Rolstad S, Klang O, et al. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. J Int Neuropsychol Soc. 2008;14:582–90. - PubMed

Publication types

MeSH terms